mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis
NCT05023954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 330
Last updated 2021-08-27
Summary
A prospective observational cohort study investigating physiological parameters vs biological markers of whole blood in septic and non-septic pregnant woman to predict systemic immune health
Conditions
- Sepsis
- Maternal Sepsis
- Maternal Sepsis During Labor
- SIRS
- Pregnancy; Infection
Interventions
- DIAGNOSTIC_TEST
-
Blood test
Drop of blood for RNA and metabolic analysis
Sponsors & Collaborators
-
Cardiff and Vale University Health Board
collaborator OTHER_GOV -
Cardiff University
lead OTHER
Principal Investigators
-
Peter Ghazal, PHD · Cardiff University
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-12
- Primary Completion
- 2022-04-01
- Completion
- 2022-09-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
NCT03188900 ·Status: COMPLETED
-
Obesity and Adipose Tissue Inflammation in Pregnant Mothers
NCT03412981 ·Status: COMPLETED
-
Biomarkers in Obstetrical Complications
NCT03480139 ·Status: COMPLETED
-
Inflammatory Biomarkers for the Diagnosis of oPRES
NCT05433870 ·Status: COMPLETED
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
NCT05445544 ·Status: RECRUITING
-
Perinatal Infections in Pakistan
NCT00070746 ·Status: COMPLETED
-
Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia
NCT02881073 ·Status: COMPLETED ·Phase: NA
-
Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia
NCT05662995 ·Status: UNKNOWN ·Phase: NA
-
Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
NCT00485784 ·Status: COMPLETED ·Phase: NA
-
Prognosis in Pregnant With COVID-19
NCT04409249 ·Status: COMPLETED
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Cardiometabolic Health in First Time Pregnancy
NCT05856318 ·Status: RECRUITING
-
Preeclampsia Ratio (sFlt-1/PlGF)
NCT03289611 ·Status: COMPLETED ·Phase: NA
-
Pregnant Women With Heart Disease in Southwestern China
NCT05144412 ·Status: COMPLETED
-
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
NCT02357667 ·Status: COMPLETED
-
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 3)
NCT06160349 ·Status: ENROLLING_BY_INVITATION
-
Placental Growth and Adverse Pregnancy Outcomes
NCT01669525 ·Status: COMPLETED
-
Establish the Referenc Range of Antiphospholipid Antibody in Healthy Preganany Women
NCT05883189 ·Status: UNKNOWN
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
NCT05197621 ·Status: RECRUITING
-
Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies
NCT04515108 ·Status: COMPLETED
-
Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia
NCT02699437 ·Status: COMPLETED
-
Improving Women's and Children's Health Via Biobanking and Electronic Registry
NCT03938129 ·Status: COMPLETED
-
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 2)
NCT06148532 ·Status: ENROLLING_BY_INVITATION